GeminIQ Website Logo

Viewing BJDX free

Subscribe for full history, 90+ metrics, screener, watchlist...

Bluejay Diagnostics, Inc.

BJDX

Companies in Surgical & Medical Instruments & Apparatus

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
453434683255
Prepaid Expense And Other Assets Current
000001111111
Deferred Offering Costs
--0------0--
Assets Held For Sale Not Part Of Disposal Group Cu…
00----------
Assets Current
453545793377
Property Plant And Equipment Net
221112221111
Operating Lease Right Of Use Asset
000000000000
Other Assets Noncurrent
000000000000
Assets
6756578115588
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
000010000010
Operating Lease Liability Current
000000000000
Accounts Payable And Other Accrued Liabilities Cur…
111111111121
Notes Payable Current
-------0----
Liabilities Current
111111122232
Operating Lease Liability Noncurrent
-00000000000
Other Liabilities Noncurrent
000000000000
Liabilities
111111122232
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
484744444040404033303029
Retained Earnings Accumulated Deficit
-43-42-40-38-37-35-33-32-29-27-25-22
Stockholders Equity
464546793356
Liabilities And Stockholders Equity
6756578115588
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
250250250250250250250300300111313
Common Stock Shares Issued
222111100971011162,7882,303
Shares Outstanding
141515151717181819191918

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202617.58%60.99%----------
202524.31%-9.94%-17.13%-7.41%1.36%57.14%-17.20%-55.41%-47.77%5.38%2.10%3.23%
2024-17.52%-85.81%-86.90%-49.66%-55.03%-71.81%-24.73%-22.15%-4.52%-55.23%-51.47%-58.18%
2023-18.67%-12.33%30.50%-44.37%-49.42%-52.52%2.22%-61.27%-75.56%-31.51%-27.77%-36.49%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.81
4.88
2.92
4.56
2.71
6.05
6.26
4.38
2.26
1.82
2.33
3.59
Quick Ratio
2.62
4.64
2.77
4.27
2.37
5.31
5.49
3.92
1.74
1.40
1.81
2.78
Working Capital
2.55M
4.34M
2.20M
3.71M
2.26M
4.09M
5.52M
6.96M
1.92M
1.45M
3.73M
4.75M
Leverage & Debt
Debt to Equity
0.34
0.19
0.32
0.21
0.37
0.16
0.17
0.26
0.51
0.68
0.58
0.33
Interest Coverage TTM
-8,346.71
-8,287.21
-1,095.28
-34.15
-8.06
-8.71
-9.88
-14.45
-
-
-
-
Debt Ratio
0.25
0.16
0.24
0.17
0.27
0.14
0.14
0.20
0.34
0.41
0.37
0.25
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.02
0.00
Per Share Metrics
Diluted EPS TTM
-7.01
-7.63
-8.70
-28.78
-29.57
-30.45
-30.43
-12.98
-11.01
-11.26
-11.28
-12.97
Free Cash Flow Per Share TTM
-6.58
-6.74
-7.69
-9.87
-10.07
-11.82
-13.31
-11.85
-9.13
-10.20
-10.49
-12.35
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-
-
-
-
-
-
-
-
-
-
4,167.24%
-
Net Profit Margin TTM
-
-
-
-
-
-
-
-
-
-
4,030.44%
-
Growth Metrics
Net Revenue Growth (1Y)
-
-
-
-
-
-
-100.00%
-
-100.00%
-100.00%
-150.00%
-100.00%
Net Income Growth (1Y)
-66.29%
-67.30%
-68.59%
112.22%
110.18%
110.38%
117.30%
-12.10%
-0.82%
7.07%
9.04%
43.83%
EPS Growth (1Y)
-76.29%
-74.96%
-71.41%
121.75%
168.51%
170.48%
169.70%
0.07%
-7.90%
-1.55%
-0.39%
41.59%
Valuation Metrics
P/E TTM
-0.26
-0.35
-0.70
-0.24
-0.50
-0.64
-0.83
-10.77
-116.67
-173.39
-613.94
-648.97
P/B TTM
0.43
0.40
1.30
0.90
2.67
2.34
2.54
11.72
337.57
596.21
1,182.08
1,088.95
P/S TTM
-
-
-
-
-
-
-
-
-
-
-24,744.57
-
Market Cap
1.81M
2.40M
4.79M
4.77M
10.33M
13.40M
18.20M
101.32M
1.14B
1.73B
6.16B
6.94B
Enterprise Value
-1.87M
-2.77M
1.70M
328.61K
7.22M
9.09M
12.45M
93.41M
1.13B
1.72B
6.16B
6.94B
Calculated Values
Free Cash Flow TTM
-6.48M
-6.05M
-6.05M
-6.85M
-6.98M
-8.13M
-9.54M
-8.59M
-8.08M
-9.02M
-9.34M
-10.19M
Net Debt
-3.68M
-5.16M
-3.08M
-4.44M
-3.12M
-4.30M
-5.76M
-7.91M
-2.66M
-2.21M
-5.08M
-5.10M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-03-14Purchase
Owner: Zeidman, Fred S
Title: -
Shares: 12,500
Price/Share: $2.00
Value: $25,000.00
Shares Owned: 12,500
Relationship: Director
Ownership: Direct
2026-03-14Purchase
Owner: Chase, Donald R
Title: -
Shares: 12,500
Price/Share: $2.00
Value: $25,000.00
Shares Owned: 12,525
Relationship: Director
Ownership: Direct
2026-03-14Purchase
Owner: Dey, Svetlana
Title: -
Shares: 12,500
Price/Share: $2.00
Value: $25,000.00
Shares Owned: 12,501
Relationship: Director
Ownership: Direct
2026-03-14Purchase
Owner: Wurth, Douglas Clark
Title: -
Shares: 12,500
Price/Share: $2.00
Value: $25,000.00
Shares Owned: 12,608
Relationship: Director
Ownership: Direct
2026-03-14Purchase
Owner: Dey, Indranil
Title: President and CEO
Shares: 12,500
Price/Share: $2.00
Value: $25,000.00
Shares Owned: 12,522
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
5.97%
Inst. Shares: 58,829
Shares Outstanding: 984,668
2025-12-31
18.75%
Inst. Shares: 168,433
Shares Outstanding: 898,086
2025-09-30
11.92%
Inst. Shares: 93,855
Shares Outstanding: 787,268
2025-06-30
14.27%
Inst. Shares: 98,995
Shares Outstanding: 693,559
2025-03-31
0.37%
Inst. Shares: 2,575
Shares Outstanding: 692,515

Bluejay Diagnostics, Inc. (BJDX) — SEC Financial Statements & Analysis

Bluejay Diagnostics, Inc. (BJDX) is a surgical & medical instruments & apparatus company, incorporated in DE. Bluejay Diagnostics, Inc. trades on Nasdaq as: BJDX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bluejay Diagnostics, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.34x, a Price-to-Sales (P/S) ratio of -24744.57x (TTM), a Price-to-Book (P/B) ratio of 0.43 (TTM), at a market cap of $1.81M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-100.00%
Debt To Equity
0.34x
P/S TTM
-24744.57x
P/B TTM
0.43
Market Cap
$1.81M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bluejay Diagnostics, Inc. in?

Bluejay Diagnostics, Inc. (BJDX) operates in the Surgical & Medical Instruments & Apparatus industry.

What is BJDX's market cap?

Bluejay Diagnostics, Inc. (BJDX) has a market capitalization of $1.81M as of 2026-03-31.

What exchange does BJDX trade on?

Bluejay Diagnostics, Inc. (BJDX) trades on the Nasdaq.

Where is Bluejay Diagnostics, Inc. incorporated?

Bluejay Diagnostics, Inc. is incorporated in DE.

Research Faster.
Invest Smarter.

Bluejay Diagnostics, Inc. (BJDX) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.